Delivery Order SPE2DB22D9311-SPE2DB25FP6YG
Award Date
3/24/25
Potential Completion Date
4/14/25
Potential Value
$4.5K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of EXPAREL 133 MG/10 ML VIAL 10ML. The delivery order, valued at $5,711.28, has a completion date of May 30, 2024 and was awarded on May 8, 2024. DMS Pharmaceutical Group holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued up to $499,999,999, that allows the agency to issue delivery orders for...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide EXPAREL 266 MG/20 ML VIAL 20ML. This $49,744.40 delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with DMS Pharmaceutical Group to fulfill recurring pharmaceutical supply needs for military health facilities worldwide. The IDC, which runs through December 31, 2025, allows the DLA...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the provision of EXPAREL 133 MG/10 ML VIAL 10ML. This $1,427.82 contract award is part of a larger $499,999,999 indefinite delivery contract (IDC) vehicle under the DLA's SPE2DB program, which enables the agency to fulfill recurring pharmaceutical supply needs of military health facilities worldwide. DMS Pharmaceutical...
The Defense Logistics Agency (DLA) awarded a Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of EXPAREL 266 MG/20 ML VIAL 20ML. The firm-fixed-price contract has a potential value of $9,948.88 and a completion date of March 25, 2024. This Delivery Order contract is part of a larger Indefinite Delivery Vehicle (IDV) contract, contract 4600082013 under the SPE2DB program, valued at up to $4,999,999 through the end of 2025. Under this IDV,...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The $7,461.66 order is for EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. The delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with DMS Pharmaceutical Group that runs through December 31, 2025. This IDC allows the DLA to issue firm...
The Defense Logistics Agency (DLA) awarded a $9,948.88 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a specialized pharmaceutical product, with a period of performance through December 2, 2024. This delivery order is placed against DMS Pharmaceutical Group's existing $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,145.70 contract is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. This delivery order is placed under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the delivery of EXPAREL 1.3% 20ML 10S. The contract, valued at $14,923.32, has a completion date of May 16, 2024 and is not set aside. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program to provide a wide range of pharmaceutical products...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of 4565110027 EXPAREL 133 MG/10 ML VIAL 10ML. The contract has a ceiling value of $8,566.92 and an ultimate completion date of July 29, 2024. This delivery order is part of a larger single-award indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA, valued at up to $499,999,999, that runs through...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 266 mg/20 ml vials of the pharmaceutical product EXPAREL. The order has a potential value of $9,952.44 and a completion date of January 11, 2024. This order is placed under a larger indefinite delivery contract held by DMS Pharmaceutical Group with DLA to provide a variety of pharmaceuticals and medical supplies to support military treatment...